Human immunodeficiency virus type 1 particles pseudotyped with envelope proteins that fuse at low pH no longer require Nef for optimal infectivity
about
Ebola virus uses clathrin-mediated endocytosis as an entry pathway.HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporationLow pH is required for avian sarcoma and leukosis virus Env-dependent viral penetration into the cytosol and not for viral uncoatingVirus entry, assembly, budding, and membrane raftsRemodeling of the Host Cell Plasma Membrane by HIV-1 Nef and Vpu: A Strategy to Ensure Viral Fitness and PersistenceThe identification of a small molecule compound that reduces HIV-1 Nef-mediated viral infectivity enhancementThe avian retrovirus avian sarcoma/leukosis virus subtype A reaches the lipid mixing stage of fusion at neutral pH.Human immunodeficiency virus type 1 Nef associates with lipid rafts to downmodulate cell surface CD4 and class I major histocompatibility complex expression and to increase viral infectivity.Sequential roles of receptor binding and low pH in forming prehairpin and hairpin conformations of a retroviral envelope glycoproteinNef does not contribute to replication differences between R5 pre-AIDS and AIDS HIV-1 clones from patient ACH142Inefficient Nef-mediated downmodulation of CD3 and MHC-I correlates with loss of CD4+T cells in natural SIV infectionRole of human immunodeficiency virus type 1 integrase in uncoating of the viral core.Nef enhances human immunodeficiency virus type 1 infectivity resulting from intervirion fusion: evidence supporting a role for Nef at the virion envelope.Restoration of wild-type infectivity to human immunodeficiency virus type 1 strains lacking nef by intravirion reverse transcription.MLV glycosylated-Gag is an infectivity factor that rescues Nef-deficient HIV-1.Nef decreases HIV-1 sensitivity to neutralizing antibodies that target the membrane-proximal external region of TMgp41.Characterization of producer cell-dependent restriction of murine leukemia virus replicationHuman immunodeficiency virus type 1 nucleocapsid zn(2+) fingers are required for efficient reverse transcription, initial integration processes, and protection of newly synthesized viral DNA.Mechanistic aspects of HIV-1 reverse transcription initiation.Evidence for a functional link between uncoating of the human immunodeficiency virus type 1 core and nuclear import of the viral preintegration complex.Effects of microtubule modulators on HIV-1 infection of transformed and resting CD4 T cells.Package of NDV-pseudotyped HIV-Luc virus and its application in the neutralization assay for NDV infection.Efficiency of human immunodeficiency virus type 1 postentry infection processes: evidence against disproportionate numbers of defective virions.The Glycoproteins of All Filovirus Species Use the Same Host Factors for Entry into Bat and Human Cells but Entry Efficiency Is Species Dependent.The trinity of the cortical actin in the initiation of HIV-1 infectionIntracellular trafficking of retroviral vectors: obstacles and advances.Cellular factors implicated in filovirus entryIntracellular trafficking of plasmids for gene therapy: mechanisms of cytoplasmic movement and nuclear importRetroviral proteins that interact with the host cell cytoskeletonThe frantic play of the concealed HIV envelope cytoplasmic tail.Nef can enhance the infectivity of receptor-pseudotyped human immunodeficiency virus type 1 particles.The Nef-infectivity enigma: mechanisms of enhanced lentiviral infection.The activity of Nef on HIV-1 infectivityNef enhances HIV-1 infectivity via association with the virus assembly complex.Nef-mediated enhancement of cellular activation and human immunodeficiency virus type 1 replication in primary T cells is dependent on association with p21-activated kinase 2.As(2)O(3) enhances retroviral reverse transcription and counteracts Ref1 antiviral activity.Vpx complementation of 'non-macrophage tropic' R5 viruses reveals robust entry of infectious HIV-1 cores into macrophages.The human immunodeficiency virus type 1 Nef and Vpu proteins downregulate the natural killer cell-activating ligand PVR.Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection.Nef enhances human immunodeficiency virus type 1 infectivity in the absence of matrix
P2860
Q24301618-E74765E8-5C47-47F9-AA61-8D564BDB8F75Q24338895-30D00D75-1B98-4C96-B0CC-75B75693C5B1Q24562016-53C15554-D3E1-427F-B007-E2576AD4AB7DQ24673161-32F001DC-3C11-4C3A-BDA1-DED513049EB4Q26767362-F2F1B745-F536-4DF2-A789-7451FDCA3A07Q28477983-EA3DAD6A-EC1A-4B86-9C23-03A2CC020B46Q30310511-BA946F28-7E63-4C74-8086-F75FFF0D5925Q30312050-81B701BC-A2DD-4B6D-88E2-352DD65B37B1Q30433973-3A7262AF-84F0-44C1-BA4F-23B2D3A3EDCFQ30441489-C35DBEE8-32A6-4B66-95A4-7523F7CA9452Q33352696-909D0DDD-409E-484C-9D85-AF77E7B832FEQ33826918-A20D5EA3-576A-453B-8F22-FE0F83E692A9Q33842252-4CA590FB-B9F9-40E9-9468-0663AC7C66D4Q33869997-41EF6410-5067-403C-A003-0AF17B9D7163Q33927183-99F2C188-8A51-43B5-9E16-B7604444D944Q34109778-47955F21-F317-4DE9-A094-4708AA40E551Q34341128-DCBD012F-135D-4FD9-9A00-E51E98AE602CQ34464770-D61A81BF-9B3D-4EC2-BA54-6C2570F216CEQ34490256-F6D7B3ED-7807-4638-AD9A-B3D4F7633B70Q34546004-58FD8DA9-EF29-4C6C-A988-5EDA397457F8Q34742816-EE689D73-04FC-45A1-8FDA-16095FD1841CQ35189635-DD6C0888-7E27-4F16-8038-6323512D67F2Q35785356-9B882835-306E-4CBE-B345-3C098221F5B3Q35930819-F482A704-35F7-417A-96A1-05C271E3DC9FQ36156531-7EACCA9A-D1A2-43EF-9401-E91B78407811Q36314656-7028ABE9-EBD7-4DC0-B52C-877CDDE6E172Q36567284-1F553304-A172-442B-97F1-F8396FCE3A4BQ36683376-2F255BEB-B961-4B98-9505-3FF9AA3A03D1Q36913964-E12A7391-8501-4F93-9618-42E3F295E8B0Q36940646-CEC10788-D844-4570-A3DF-4CB7686FE0AAQ36949578-1C9EEA68-F0BD-46B7-93EC-CFB32C3D5705Q37959034-2C1C8CF3-E840-496E-A668-CF4D3EDA2E39Q38218107-F5D30DBF-6887-4C44-8B7A-774411EE85BBQ38294613-E8F435ED-DEA2-44C3-9552-699B1C6DFDBDQ38356666-6F0D7CC4-F14A-45E2-9B0B-8E92C76A76DDQ38906287-A00C6538-E041-432E-BBBD-1B9D1EA5BAB9Q38936957-2C0B4E3A-8C9E-4419-94C0-9E05EF0E7C08Q39402500-3E523C36-D1BC-4F22-A7F9-68B2D1EF9073Q39593653-57709FD5-E090-4A63-88B9-9888F58094BAQ39683897-B02855EB-0CF5-44CD-A18A-2C6B7F97F0CB
P2860
Human immunodeficiency virus type 1 particles pseudotyped with envelope proteins that fuse at low pH no longer require Nef for optimal infectivity
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Human immunodeficiency virus t ...... re Nef for optimal infectivity
@ast
Human immunodeficiency virus t ...... re Nef for optimal infectivity
@en
type
label
Human immunodeficiency virus t ...... re Nef for optimal infectivity
@ast
Human immunodeficiency virus t ...... re Nef for optimal infectivity
@en
prefLabel
Human immunodeficiency virus t ...... re Nef for optimal infectivity
@ast
Human immunodeficiency virus t ...... re Nef for optimal infectivity
@en
P2093
P2860
P1433
P1476
Human immunodeficiency virus t ...... re Nef for optimal infectivity
@en
P2093
P2860
P304
P356
10.1128/JVI.75.8.4014-4018.2001
P577
2001-04-01T00:00:00Z